“…PURPOSE: Viral hepatitis B and C represent the primary health challenge confronting Asia and Pakistan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Hepatitis B virus (HBV) infection is assumed to be the major cause of chronic liver disease (CLD) in sub-Saharan Africa. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Therefore, to precisely assess therapeutic efficacy on chronic hepatitis B (CHB), we explored the utility of qFibrosis (a fully-quantitative morphometric method employing second harmonic generation/two photon excitation fluorescence) in liver fibrosis evaluation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Items of screening examinations included questionnaire, blood sampling for liver tests and viral hepatitis markers (hepatitis B surface antigen and anti-HCV antibody), abdominal sonography survey, and liver stiffness measurement by transient elastography. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…AgNPs have been used in vitro for treatment of various diseases, such as hepatitis B and herpes simplex infections as well as colon, cervical, and lung cancers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: While 3 patients were positive for hepatitis-B surface antigen, 2 had cirrhosis. The largest tumor diameter ranged from 5.0 to 21.0 cm. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The decreased incidence of VL in children was associated with improved nutritional status and childhood immunizations including measles, poliomyelitis, BCG, and hepatitis B. Human VL correlated temporally and geographically with canine L. infantum infection (p = 0.002, R(2) = 0.438), with rainfall and with Lutzomyia longipalpis density (r = 0.762). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There was supportive evidence that cervical screening and hepatitis B immunisation prevent cancer in LLMICs. A single randomised controlled trial supported polypharmacy for cardiovascular disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis B virus (HBV) infection is a common problem in the world, especially in China. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Vaccination with synthetic long peptides (SLP) is a promising new treatment strategy for chronic hepatitis B virus (CHB). SLP can induce broad T-cell responses for all HLA types. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Principal component analysis using the 3331 probes revealed distinct DNA methylation profiles of NASH-N samples that were different from those of NLT samples and 37 samples of non-cancerous liver tissue showing chronic hepatitis or cirrhosis associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (viral-N). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Over the past 30 years, the top five types of PGN were immunoglobulin A nephropathy (IgAN; 24.3%), mesangial proliferative glomerulonephritis (MsPGN; 10.5%), membranous nephropathy (MN; 12.6%), minimal change disease (MCD; 9.8%), and focal segmental glomerulosclerosis (FSGS; 4.6%), and the top four types of SGN were lupus nephritis (LN; 8.6%), Henoch-Schönlein purpura glomerulonephritis (4.1%), hepatitis B virus-associated glomerulonephritis (HBV-GN; 2.6%), and diabetic nephropathy (DN; 1.6%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Furthermore, the supernatant from cultured adefovir-treated colon cancer cells significantly induced IFN-stimulated genes (ISGs) and inhibited hepatitis B surface antigen (HBsAg) production in hepatoma cells, as compared with the supernatant from entecavir-treated cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CASE REPORT: We present a 32-year-old female intravenous drug abuser, positive for Hepatitis B and C who had started to inject her femoral veins 2 years ago. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Current therapies for chronic hepatitis B virus (HBV) infections are effective at decreasing the viral load in serum, but do not lead to viral eradication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In contrast, there was no evidence of departure from linearity among patients with hepatitis B virus infection (P (nonlinearity) = 0.072). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Nine clinical trials compared TAF and TDF for treatment of HIV-1 and two were for hepatitis B treatment. The eleven clinical trials documented 4574 patients with boosting RTV or COBI in both arms, covering 7198 patient-years of follow-up. …”
Enlace del recurso
Enlace del recurso

“…The heterogeneity observed could be explained by WHO region, comorbid hypertension and diabetes mellitus, but not by gender, hepatitis B or C coinfection, CD4 count or antiretroviral status. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We enrolled 7,905 Japanese subjects who had received annual health checkups more than twice between April 2003 and August 2013, 4,045 of whom met at least one of the following exclusion criteria and were excluded: (a) fatty liver at baseline; (b) hepatitis B or hepatitis C; (c) alcohol consumption (men: ≥210 g/wk; women: ≥140 g/wk); (d) change in alcohol drinking status between baseline and the study’s endpoint; (e) change in cigarette smoking habits between baseline and the study’s endpoint; or (f) current treatment with antidiabetic agents, antihypertensive agents, and/or lipid-lowering agents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PATIENTS AND METHODS: This study was conducted on 54 obese patients, with suspected fatty liver by ultrasound (excluding diabetic, alcoholic, hepatitis C virus antibody (HCVAb) or hepatitis B surface antigen (HBsAg) positive patients). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso